United Therapeutics Corporation (UTHR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for United Therapeutics Corporation, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$586.48
−0.80% today
Market cap
$25.4B
Overall quality
—
Kronos AI 30-day
−11.4%
0 of 8 simulated paths end higher
United Therapeutics Corporation (UTHR) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $25.4B. It trades at $586.48, down 0.80% today. 14 analysts' average target of $669.21 implies +14.1% from today's price. Kronos AI's 30-day forecast is −11.4% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $669.21 |
| Low – high | $368.00 – $850.00 |
| Analysts | 14 |
| Upside to average | +14.1% |
Kronos AI 30-day forecast
| Expected close | $523.63 (−11.4%) |
| Likely range | −12.7% … −8.6% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.